Wednesday, June 1, 2016

BRIEF-Moody's downgrades AbbVie to Baa2; stable outlook

* Baa2 rating reflects its large scale with a revenues of

about $23 billion, its high margins and its strong cash flow

Read more

No comments:

Post a Comment